Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: A study of fourteen cases and literature review

Rheumatology International

Volumn 33, Issue 10, 2013, Pages 2455-2458

  Chen, Dan ^a   Wang, Xiao Bing ^a   Zhou, Yan ^a   Zhu, Xiao Chun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute interstitial pneumonia; Dermatomyositis; Infliximab; Treatment

Indexed keywords

ALBUMIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G4; INFLIXIMAB; JO 1 ANTIBODY; LA ANTIBODY; LACTATE DEHYDROGENASE;

ADULT; ALBUMIN BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DRUG EFFICACY; ELECTROMYOGRAPHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION TEST; MYOSITIS; PRIORITY JOURNAL; RASH; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; REVIEW; TACHYPNEA;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84885375272     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2653-4     Document Type: Review

References (10)

1. Ye S, Chen XX, Lu XY et al (2007) Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 26:1647-1654
2. Santmyire-Rosenberger B, Dugan EM (2003) Skin involvement in dermatomyositis. Curr Opin Rheumatol 15:714-722
3. Yoshinari D, Takeyoshi I, Koibuchi Y et al (2001) Effects of a dual inhibitor of TNF-α and IL-1 on lipopolysaccharide-induced lung injury in rats. Crit Care 5: P083-S39
4. Hassan AB, Nikitina-Zake L, Sanjeevi CB et al (2004) Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03)with polymyositis and dermatomyositis. Arthr Rheumatol 50:1013-1015
5. Fathi M, Dastmalchi M, Rasmussen E et al (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheumatol Dis 63:297-301
6. Wei QH, Jin YL, Yang HT et al (2007) Clinical analysis of 7 dermatomyositis cases with acute interstitial pneumonia and literature review. Clin J Rheumatol 11:301-303
7. Kameda H, Nagasawa H, Oqawa H et al (2005) Combination therapy with corticosteroids, cyclosporine A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. Rheumatology 32:1719-1726
8. Hengstman GJD, van den Hoogen FHJ, van Engelen BGM (2009) Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother 10:1183-1190
9. Takahisa G, Yasushi K, Takashi S et al (2010) Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 49:1713-1719
10. Ji SY, Zeng FQ, Guo Q et al (2010) Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. Chin Med J Engl 123:517-522